Therapeutic potentials of short interfering RNAs

Area of Science:

• Molecular Biology
• Genetics
• Biotechnology

Background:

• Short interfering RNA (siRNA) is a key component of RNA interference (RNAi).
• siRNA functions with the RNA-induced silencing complex (RISC) to degrade target RNAs, acting as a cellular defense mechanism.
• The discovery of endogenous siRNAs (endo-siRNAs) in reproductive cells suggests roles in cell division regulation.

Purpose of the Study:

• To explore the therapeutic potential of siRNA in gene silencing for various diseases.
• To review the mechanisms by which siRNA can inhibit viral replication, tumorigenesis, inflammation, and cardiovascular diseases.
• To discuss advancements in siRNA delivery systems and their impact on efficacy.

Main Methods:

• Review of existing literature on siRNA mechanisms and applications.
• Analysis of preclinical and clinical studies on siRNA-based therapies.
• Examination of various siRNA delivery systems, including viral vectors, nanoparticles, and inorganic molecules.

Main Results:

• siRNA demonstrates efficacy in inhibiting viral infections, suppressing tumor growth, and managing inflammatory and cardiovascular diseases.
• Structural modifications of siRNA improve delivery, specificity, efficacy, and bioavailability.
• Multiple delivery systems, including lipid-based, peptide-based, and polymer-based nanoparticles, are effective for siRNA delivery.

Conclusions:

• siRNA represents a promising therapeutic strategy for targeted treatment of diverse diseases.
• Advancements in siRNA delivery systems are crucial for enhancing therapeutic outcomes.
• Further preclinical and clinical research supports the future potential of siRNA as a medicine.